In this study, knocking out IL-17 significantly promoted the expression of BrdU, DCX, Nestin, and Sox2 in the SGZ after stroke in vivo (Figures 5A–D), which was consistent with the results by giving As IV above (Figures 2A, D). The gene discussed is SOX2; the disease is Stroke.